Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Dexiang Gao
Affiliation
University of Colorado Anschutz Medical Campus
ORCID
Career Start Year
2001
Papers
142
H Index
38
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36378549
Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma.
Clin Cancer Res
2023
37828812
Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low-income adults.
Stat Med
2023
37606183
Integrated variant allele frequency analysis pipeline and R package: easyVAF.
Mol Carcinog
2023
35624328
Adoption of Optimal Small (6-9Â mm) Colorectal Polyp Resection Technique Over Time.
Dig Dis Sci
2023
37157185
CCR4-IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T-cell lymphoma in a mouse CTCL model.
FEBS Open Bio
2023
37389416
The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma.
J Natl Cancer Inst
2023
37246777
Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study.
Neuro Oncol
2023
37210417
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
NPJ Breast Cancer
2023
37142267
Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE).
J Natl Cancer Inst
2023
37363965
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.
Clin Cancer Res
2023
37360690
Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling.
iScience
2023
37197667
<i>CTLA4</i> mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood <i>CTLA4</i> levels are associated with poor prognosis in metastatic melanoma patients.
Front Immunol
2023
36641932
Multicenter analysis of stereotactic radiosurgery for multiple brain metastases from EGFR and ALK driven non-small cell lung cancer.
Lung Cancer
2023
36726177
Equivocal end-of-therapy imaging findings do not predict a higher risk of local relapse after definitive radiotherapy in pediatric Ewing sarcoma and rhabdomyosarcoma.
Pediatr Blood Cancer
2023
34767934
Results of a Multi-Institutional Phase 2 Clinical Trial for 4DCT-Ventilation Functional Avoidance Thoracic Radiation Therapy.
Int J Radiat Oncol Biol Phys
2022
35605559
The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
Oral Oncol
2022
35533965
Co-delivery of Docetaxel and Resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer.
Eur J Pharm Sci
2022
35366939
Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers.
J Exp Clin Cancer Res
2022
35525161
Overall survival is the lowest among young women with postpartum breast cancer.
Eur J Cancer
2022
36100512
The Effect of Intrathoracic Lesion Location on Initial Tyrosine Kinase Inhibitor Response in Advanced Oncogene-Addicted Non-Small Cell Lung Cancer: A Comparison Between RECIST 1.1 and a Novel Method of Response Assessment (MAX).
Clin Lung Cancer
2022
35961935
Oncogene Overlap Analysis of Circulating Cell-free Tumor DNA to Explore the Appropriate Criteria for Defining MET Copy Number-Driven Lung Cancer.
Clin Lung Cancer
2022
34876360
Gynecologic interstitial brachytherapy curriculum using a low-cost phantom with ultrasound workshop and a treatment planning workshop is effective.
Brachytherapy
2022
35332157
Sexual dimorphic impacts of systemic vincristine on lower urinary tract function.
Sci Rep
2022
33414263
Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
J Immunother Cancer
2021
35990801
Global melanoma correlations with obesity, smoking, and alcohol consumption.
JMIR Dermatol
2021
33540470
A novel diphtheria toxin-based bivalent human EGF fusion toxin for treatment of head and neck squamous cell carcinoma.
Mol Oncol
2021
33674224
A Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Versus Pembrolizumab Plus Axitinib and Versus Avelumab Plus Axitinib in First-Line Treatment of Advanced Renal Cell Carcinoma.
Clin Genitourin Cancer
2021
33816286
Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials.
Front Oncol
2021
34218684
Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.
Clin Trials
2021
34245214
A prospective survey study of lower urinary tract dysfunction in childhood cancer survivors after vincristine and/or doxorubicin chemotherapy.
Pediatr Blood Cancer
2021
34119517
Early-Age Onset Colorectal Neoplasia in Average-Risk Individuals Undergoing Screening Colonoscopy: A Systematic Review and Meta-Analysis.
Gastroenterology
2021
33436027
Advanced adenomas may be a red flag for hereditary cancer syndromes.
Hered Cancer Clin Pract
2021
33087417
Studying Immunotherapy Resistance in a Melanoma Autologous Humanized Mouse Xenograft.
Mol Cancer Res
2021
33069585
Prostate Cancer Central Nervous System Metastasis in a Contemporary Cohort.
Clin Genitourin Cancer
2021
32353598
Variation in Toxicity Reporting Methods for Early Phase Lung Cancer Treatment Trials at Oncology Conferences.
J Thorac Oncol
2020
31781896
The impact of age at orchiopexy on testicular cancer outcomes.
World J Urol
2020
33088913
Semaphorin 7a is a biomarker for recurrence in postpartum breast cancer.
NPJ Breast Cancer
2020
33063469
Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center.
Cancer Med
2020
32916850
Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15<sup>+</sup> Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma.
Int J Mol Sci
2020
32684283
Reply to Letter to the Editor.
J Pediatr Surg
2020
32496550
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study.
JAMA Oncol
2020
32409174
Lymph node yield in pediatric, adolescent and young adult Renal Cell Carcinoma - How many are enough?
J Pediatr Surg
2020
30306797
Algorithm to Predict Which Children With Chronic Abdominal Pain Are Low Suspicion for Significant Endoscopic Findings.
Clin Pediatr (Phila)
2019
31781510
IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients.
Front Oncol
2019
31580832
Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.
Chem Biol Interact
2019
31576334
Extended follow-up on KEYNOTE-024 suggests significant survival benefit for pembrolizumab in patients with PD-L1 â¿¥50%, but unanswered questions remain.
Ann Transl Med
2019
31282194
Obstructive Sleep Apnea and Sleep Position: Does It Matter for Infants With a Cleft Palate?
Cleft Palate Craniofac J
2019
31255328
How many lymph nodes are enough? Assessing the adequacy of lymph node yield for staging in favorable histology wilms tumor.
J Pediatr Surg
2019
31099111
Interleukin-37 is highly expressed in regulatory T cells of melanoma patients and enhanced by melanoma cell secretome.
Mol Carcinog
2019
30808730
Urea Cycle Sustains Cellular Energetics upon EGFR Inhibition in EGFR-Mutant NSCLC.
Mol Cancer Res
2019
1 - 50 of 142
Column Actions
Search
Recommended Authors
Matthew R Buras
Mayo Clinic
Career Start Year
2017
Number of shared co-authors
0
Tristan Grogan
University of California Los Angeles
Career Start Year
2013
Number of shared co-authors
0
Matthew A Hathcock
Mayo Clinic
Career Start Year
2013
Number of shared co-authors
1
Colin O'Rourke
Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year
2011
Number of shared co-authors
0
Yunfeng Dai
Colleges of Medicine, University of Florida
Career Start Year
2009
Number of shared co-authors
0
Rafia Bhore
Regeneron Pharmaceuticals
Career Start Year
2009
Number of shared co-authors
1
Diana Abbott
Center for Innovative Design and Analysis, University of Colorado, Aurora CO.
Career Start Year
2008
Number of shared co-authors
6
Sunita Ghosh
Cross Cancer Institute
Career Start Year
2006
Number of shared co-authors
0
Minya Pu
University of California
Career Start Year
2003
Number of shared co-authors
0
Mark E Smolkin
University of Virginia
Career Start Year
2002
Number of shared co-authors
0
Soledad Fernandez
McGill University
Career Start Year
2001
Number of shared co-authors
0
Mi-Ok Kim
University of California san francisco
Career Start Year
2000
Number of shared co-authors
0
Ronghui Xu
University of California San Diego
Career Start Year
2000
Number of shared co-authors
1
Pingfu Fu
Case Western Reserve University
Career Start Year
2000
Number of shared co-authors
0
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year
1997
Number of shared co-authors
2
Manisha Desai
Stanford University
Career Start Year
1997
Number of shared co-authors
1
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year
1997
Number of shared co-authors
1
Nam Bui
Stanford University
Career Start Year
1996
Number of shared co-authors
0
Madhu Mazumdar
Icahn School of Medicine at Mount Sinai
Career Start Year
1992
Number of shared co-authors
0
Dong Wook Kim
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Career Start Year
1992
Number of shared co-authors
0
Wei Xu
Princess Margaret Cancer Centre
Career Start Year
1991
Number of shared co-authors
1
Dhaval Patel
National Cancer Institute, National Institutes of Health
Career Start Year
1991
Number of shared co-authors
0
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year
1991
Number of shared co-authors
1
Motomi Mori
St Jude Children's Research Hospital.
Career Start Year
1988
Number of shared co-authors
4
Avital Cnaan
George Washington University
Career Start Year
1985
Number of shared co-authors
0
Brad H Pollock
University of California davis
Career Start Year
1983
Number of shared co-authors
1
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year
1983
Number of shared co-authors
0
Judith D Goldberg
NYU Grossman School of Medicine
Career Start Year
1974
Number of shared co-authors
1
Jeffrey P Krischer
Health Informatics Institute, University of South Florida
Career Start Year
1971
Number of shared co-authors
0
row(s) 1 - 29 of 29
Collaborators
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Co-authored papers
13
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers
8
Antonio Jimeno
University of Colorado School of Medicine
Co-authored papers
8
Martin D McCarter
University of Colorado School of Medicine
Co-authored papers
7
Stephen B Keysar
University of Colorado Denver
Co-authored papers
6
Rene Gonzalez
University of Colorado Anschutz Medical Campus
Co-authored papers
5
Wells A Messersmith
University of Colorado Anschutz Medical Campus
Co-authored papers
5
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Co-authored papers
5
John S Rumsfeld
Stanford University
Co-authored papers
4
Gary K Grunwald
Rocky Mountain Regional Veterans Affairs Medical Center Aurora CO USA.
Co-authored papers
4
Nicholas K Foreman
Co-authored papers
4
James DeGregori
University of Colorado Anschutz Medical Campus
Co-authored papers
3
Todd A MacKenzie
Geisel School of Medicine at Dartmouth
Co-authored papers
3
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Co-authored papers
3
Christopher C Porter
Emory University School of Medicine
Co-authored papers
2
Kathryn L Zolman
University of Colorado Anschutz Medical Campus
Co-authored papers
2
Sana D Karam
University of Colorado School of Medicine
Co-authored papers
2
Etienne Danis
University of Colorado Anschutz Medical Campus
Co-authored papers
2
Joshua D Palmer
Co-authored papers
2
Steve E Braunstein
University of California san francisco
Co-authored papers
2
Leylah M Drusbosky
College of Medicine, University of Florida
Co-authored papers
1
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers
1
Esther M John
Co-authored papers
1
Sarah Gehrke
University of Colorado Anschutz Medical Campus
Co-authored papers
1
Andrii I Rozhok
University of Colorado Anschutz Medical Campus
Co-authored papers
1
Kristian W Pajtler
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Co-authored papers
1
Christina Collins
University of Colorado Anschutz Medical Campus
Co-authored papers
1
Siddharth Singh
University of California San Diego
Co-authored papers
1
Myron J Levin
Co-authored papers
1
Adriana Weinberg
Co-authored papers
1
1 - 30